home / stock / ncna / ncna short
Short Information | NuCana plc (NASDAQ:NCNA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 190,585 |
Total Actual Volume | 715,390 |
Short Trends | |
---|---|
Cover Days | 17 |
Short Days | 0 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 9,529 |
Average Short Percentage | 25.12% |
Is there a NCNA Short Squeeze or Breakout about to happen?
See the NCNA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-16-2024 | $3.87 | $3.67 | $3.87 | $3.67 | 14,649 | 3,158 | 21.56% |
05-15-2024 | $3.852 | $3.78 | $3.9799 | $3.77 | 24,952 | 6,051 | 24.25% |
05-14-2024 | $3.68 | $3.88 | $3.88 | $3.68 | 14,051 | 4,192 | 29.83% |
05-13-2024 | $3.61 | $3.73 | $3.87 | $3.54 | 19,513 | 4,905 | 25.14% |
05-10-2024 | $3.52 | $3.59 | $3.62 | $3.41 | 17,918 | 3,632 | 20.27% |
05-09-2024 | $3.606 | $3.5 | $3.8099 | $3.4067 | 35,364 | 5,774 | 16.33% |
05-08-2024 | $4.01 | $3.67 | $4.3399 | $3.53 | 328,641 | 95,132 | 28.95% |
05-07-2024 | $3.87 | $3.91 | $4.01 | $3.87 | 5,505 | 1,903 | 34.57% |
05-06-2024 | $4 | $3.88 | $4 | $3.85 | 31,431 | 8,201 | 26.09% |
05-03-2024 | $3.91 | $4 | $4.178 | $3.89 | 28,655 | 3,303 | 11.53% |
05-02-2024 | $4.04 | $3.965 | $4.04 | $3.85 | 8,756 | 2,007 | 22.92% |
05-01-2024 | $3.94 | $3.98 | $4.095 | $3.8301 | 6,268 | 833 | 13.29% |
04-30-2024 | $4 | $3.96 | $4.011 | $3.83 | 9,444 | 2,097 | 22.2% |
04-29-2024 | $4.14 | $4 | $4.281 | $3.96 | 13,825 | 1,730 | 12.51% |
04-26-2024 | $3.89 | $4 | $4 | $3.845 | 7,152 | 3,504 | 48.99% |
04-25-2024 | $4 | $3.81 | $4 | $3.5405 | 16,552 | 3,388 | 20.47% |
04-24-2024 | $4.01 | $3.84 | $4.09 | $3.75 | 12,007 | 4,603 | 38.34% |
04-23-2024 | $4.01 | $4 | $4.13 | $3.8201 | 37,241 | 5,583 | 14.99% |
04-22-2024 | $3.85 | $3.99 | $4.2 | $3.8134 | 50,844 | 21,526 | 42.34% |
04-19-2024 | $3.7 | $3.775 | $3.82 | $3.4 | 32,622 | 9,063 | 27.78% |
News, Short Squeeze, Breakout and More Instantly...
Key Data Readouts on Track for All Programs in 2024 Randomized Phase 2 Study of 182 Second-Line Colorectal Cancer Patients Fully Enrolled NUC-7738 plus Pembrolizumab Demonstrated Encouraging Anti-Cancer Activity in Several Patients who were Resistant to PD-1 Inhibitors ...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 50.1% to $0.1783 on volume of 599,794,977 shares WiSA Technologies Inc. (WISA) rose 248.6% to $6.1 on volume of 197,912,579 shares PROSHARES TRUST (SQQQ) rose 0.0% to $11.44 on volume of 182,001,060 shar...